Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-001227)
Received: 21 December 2021
Accepted: 21 March 2022
First Online: 4 April 2022
: Animal study protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (# 020645).
: Not applicable.
: The Lundquist Institute owns patents on the SMB and B-YL peptides.